Orally administered sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice.

Ono, Kazuhiko; Nimura, Satoshi; Hideshima, Yuko; Nabeshima, Kazuki; Nakashima, Manabu

Ono, Kazuhiko; Nimura, Satoshi; Hideshima, Yuko; Nabeshima, Kazuki; Nakashima, Manabu.

Afiliación

Ono K; Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka 814-0180, Japan.
Nimura S; Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Hideshima Y; Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka 814-0180, Japan.
Nabeshima K; Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Nakashima M; Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, Fukuoka 814-0180, Japan.

Exp Ther Med ; 14(6): 5485-5490, 2017 Dec.

Article en En | MEDLINE | ID: mdl-29285080

Palabras clave

inflammation; inflammatory bowel disease; oral administration; pro-inflammatory cytokines; sodium 4-phenylbutyrate; ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Exp Ther Med Año: 2017 Tipo del documento: Article País de afiliación: Japón